Compare IMMX & RMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMX | RMIX |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 784.8M | 772.3M |
| IPO Year | 2021 | 2026 |
| Metric | IMMX | RMIX |
|---|---|---|
| Price | $7.92 | $5.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 6 |
| Target Price | ★ $24.05 | $20.83 |
| AVG Volume (30 Days) | ★ 1.2M | 606.0K |
| Earning Date | 11-12-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $127.24 |
| Revenue Next Year | N/A | $38.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.78 | $8.02 |
| 52 Week High | $15.10 | $25.50 |
| Indicator | IMMX | RMIX |
|---|---|---|
| Relative Strength Index (RSI) | 42.67 | 20.22 |
| Support Level | $7.82 | N/A |
| Resistance Level | $9.04 | $12.59 |
| Average True Range (ATR) | 0.62 | 1.17 |
| MACD | 0.16 | -0.25 |
| Stochastic Oscillator | 41.81 | 0.28 |
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Suncrete Inc is a ready-mix concrete logistics and distribution platform operating across Oklahoma and Arkansas. Ready-mix concrete is a crucial building material that is used in the vast majority of infrastructure, commercial and residential construction projects. The company's ready-mix concrete business engages principally in the precise formulation, efficient production and on-time delivery of ready-mix concrete to the customers' job sites. It serves substantially all end markets of the construction industry in the select geographic markets. The company earns revenue prominently from the production and delivery of ready-mix concrete, with the majority revenue generated from orders under master purchase agreements or through direct sales to third-party contractors and suppliers.